Zaid M. Abdelsattar, MD, MS, K

Slides:

Advertisements

Similar presentations

Robert M. Kaplan, PhD, Qiankun Sun, PhD, Keith S

Advertisements

Is Hospital Procedure Volume a Reliable Marker of Quality for Coronary Artery Bypass Surgery? A Comparison of Risk and Propensity Adjusted Operative and.

Elizabeth A. David, MD, David T

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer Jeffrey L. Port, MD, Bhupesh Parashar,

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Benny Weksler, MD, Jennifer L. Sullivan, MD

Thomas J. Birdas, MD, Richard P. M

Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD,

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Trevor Williams, MD, MPH, Brian C

Christopher W. Seder, MD, Mark S. Allen, MD, Francis C

Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J

Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy Colin Schieman, MD, Dennis A. Wigle, MD, PhD,

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Julie E. Bauman, MD, Michael.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Cooperative Group Clinical Trials in General Thoracic Surgery: Report From the 2012 Robert Ginsberg Clinical Trials Meeting of the General Thoracic Surgical.

A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients Elizabeth A. David, MD, Stina W. Andersen, PhD,

Gal Levy, MD, Mark A. Cordes, MD, Alexander S. Farivar, MD, Ralph W

Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery

Non-Small Cell Lung Cancer Resection in Lymphoma Patients

Esophagectomy Outcomes in the Endoscopic Mucosal Resection Era

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer Paul J. Speicher, MD, Zachary W. Fitch,

Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D

K. Robert Shen, MD, Mark S. Allen, MD, Stephen D

A Randomized Controlled Trial of Bupivacaine Through Intracostal Catheters for Pain Management After Thoracotomy Mark S. Allen, MD, Lisa Halgren, RN,

Surgical treatment of metachronous second primary lung cancer after complete resection of non–small cell lung cancer Masatsugu Hamaji, MD, Mark S. Allen,

Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer Justin A. Drake, MD, David C. Portnoy, MD, Kurt.

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Elizabeth H. Stephens, MD, PhD, Arlene M. Correa, PhD, Min P

Trevor Williams, MD, MPH, Brian C

Theolyn N. Price, MD, Mark S. Allen, MD, Francis C

Surgical Resection of Rare Esophageal Cancers

Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer Usman Ahmad, MD, Traves D. Crabtree,

Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Thomas J. Birdas, MD, Richard P. M

The Society of Thoracic Surgeons General Thoracic Surgery Database: Establishing Generalizability to National Lung Cancer Resection Outcomes Damien J.

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Characteristics Associated With the Use of Nonanatomic Resections Among Medicare Patients Undergoing Resections of Early-Stage Lung Cancer Anthony W.

Treatment of Postsurgical Chylothorax

Survival After Lobectomy Versus Segmentectomy for Stage I Non-Small Cell Lung Cancer: A Population-Based Analysis Bryan A. Whitson, MD, PhD, Shawn S.

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Prediction of Surgical Outcome by Modeling Based on Risk Factors of Morbidity After Pulmonary Resection for Lung Cancer in Older Adults Yuzhao Wang,

Survival After Surgical Resection of Stage IV Esophageal Cancer

Variation in Hospital Adoption Rates of Video-Assisted Thoracoscopic Lobectomy for Lung Cancer and the Effect on Outcomes Zaid M. Abdelsattar, MD, MS,

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,

Asvin M. Ganapathi, MD, Paul J. Speicher, MD, Anthony W

Robert M. Kaplan, PhD, Qiankun Sun, PhD, Keith S

Single Versus Double Lung Retransplantation Does Not Affect Survival Based on Previous Transplant Type Erin M. Schumer, MD, MPH, Jonathan D. Rice, MD,

Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer Shanda H. Blackmon, MD, MPH, Elizabeth.

Specialty Training and Mortality After Esophageal Cancer Resection

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Bullectomy for Symptomatic or Complicated Giant Lung Bullae

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

On-Pump Versus Off-Pump Surgical Revascularization for Left Main Stem Stenosis: Risk Adjusted Outcomes John C.Y. Lu, Antony D. Grayson, BS, D. Mark Pullan

Pneumonectomy After Chemoradiation Therapy for Non-Small Cell Lung Cancer: Does “Side” Really Matter? Anthony W. Kim, MD, L. Penfield Faber, MD, William.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Induction Therapy Followed by Surgery for T3-T4/N0 Non-Small Cell Lung Cancer: Long-Term Results Filippo Lococo, MD, Alfredo Cesario, MD, Stefano Margaritora,

Presentation transcript:

Outcomes After Sleeve Lung Resections Versus Pneumonectomy in the United States Zaid M. Abdelsattar, MD, MS, K. Robert Shen, MD, Sai Yendamuri, MD, Stephen Cassivi, MD, Francis C. Nichols, MD, Dennis A. Wigle, MD, PhD, Mark S. Allen, MD, Shanda H. Blackmon, MD, MPH The Annals of Thoracic Surgery Volume 104, Issue 5, Pages 1656-1664 (November 2017) DOI: 10.1016/j.athoracsur.2017.05.086 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 (A) Overall survival stratified by the type of operation in the unmatched overall cohort. (B) Overall survival in the propensity score–matched cohort. Note that the observed difference in survival (p < 0.001) in the matched cohort is mainly realized in the first year after the operation, after which the rate of decay becomes negligible (conditional p = 0.057 at 18 months). (C) Overall survival in the propensity score matched cohort stratified by carcinoid vs non-small cell lung cancer (NSCLC) histology. The Annals of Thoracic Surgery 2017 104, 1656-1664DOI: (10.1016/j.athoracsur.2017.05.086) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Risk-adjusted perioperative outcomes stratified by hospital sleeve-to-pneumonectomy (S:P) ratio quintile. Note that the outcomes are equivalent across quintiles of S:P ratios. Univariate comparisons are made between the highest and lowest quintiles. The Annals of Thoracic Surgery 2017 104, 1656-1664DOI: (10.1016/j.athoracsur.2017.05.086) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions